Cargando…
Impact of diabetes as a risk factor in patients undergoing subcutaneous implantable cardioverter defibrillator implantation: A single-centre study
INTRODUCTION: Patients with diabetes mellitus are known to carry an increased risk for surgical site infections and perioperative complications. The subcutaneous implantable cardioverter defibrillator is an established treatment option in patients at risk for sudden cardiac death especially with an...
Autores principales: | Kaya, Elif, Siebermair, Johannes, Vonderlin, Nadine, Hadjamu, Nino, Azizy, Obayda, Rassaf, Tienush, Wakili, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510351/ https://www.ncbi.nlm.nih.gov/pubmed/32292066 http://dx.doi.org/10.1177/1479164120911560 |
Ejemplares similares
-
Use of pulsed electron avalanche knife (PEAK) PlasmaBlade™ in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillator
por: Kaya, Elif, et al.
Publicado: (2019) -
Gender Differences in Anger Among Hospital Medical Staff Exposed to Patients with COVID-19
por: Wesemann, Ulrich, et al.
Publicado: (2021) -
Subcutaneous ICD: Current standards and future perspective
por: Kaya, Elif, et al.
Publicado: (2019) -
Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017) -
The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)